Gene · 9619
Papers3,998
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,998
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Expression of Genes Related to Reverse Cholesterol Transport and Leptin Receptor Pathways in Peripheral Blood Mononuclear Cells Are Decreased in Morbid Obesity and Related to Liver Function. | Int J Mol Sci | 2024 | 39062791 | PubTator, text mining | PubMed |
| Response to Letter to the Editor From Hoekstra: "Adrenal Abcg1 Controls Cholesterol Flux and Steroidogenesis". | Endocrinology | 2024 | 39041176 | PubTator, text mining | PubMed |
| Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors. | J Immunother | 2024 | 38989743 | PubTator, text mining | PubMed |
| Alphaherpesvirus manipulates retinoic acid metabolism for optimal replication. | iScience | 2024 | 38989466 | PubTator, text mining | PubMed |
| DHA dietary intervention caused different hippocampal lipid and protein profile in ApoE-/- and C57BL/6J mice. | Biomed Pharmacother | 2024 | 38971007 | PubTator, text mining | PubMed |
| LncRNA DANCR promotes macrophage lipid accumulation through modulation of membrane cholesterol transporters. | Aging (Albany NY) | 2024 | 38968577 | PubTator, text mining | PubMed |
| Diisodecyl phenyl phosphate promotes foam cell formation by antagonizing Liver X receptor alpha. | J Hazard Mater | 2024 | 38964041 | PubTator, text mining | PubMed |
| Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation. | Int J Mol Sci | 2024 | 38928513 | PubTator, text mining | PubMed |
| Extracellular Vesicles Secreted by Adipose Tissue during Obesity and Type 2 Diabetes Mellitus Influence Reverse Cholesterol Transport-Related Gene Expression in Human Macrophages. | Int J Mol Sci | 2024 | 38928163 | PubTator, text mining | PubMed |
| Ergosterol and its metabolites as agonists of Liver X receptor and their anticancer potential in colorectal cancer. | J Steroid Biochem Mol Biol | 2024 | 38908720 | PubTator, text mining | PubMed |
| The role of ATP-binding cassette subfamily G member 1 in tumor progression. | Cancer Med | 2024 | 38896016 | PubTator, text mining | PubMed |
| Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies. | Front Cardiovasc Med | 2024 | 38883983 | PubTator, text mining | PubMed |
| HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer. | J Ovarian Res | 2024 | 38851728 | PubTator, text mining | PubMed |
| Two peptides LLRLTDL and GYALPCDCL inhibit foam cell formation through activating PPAR-γ/LXR-α signaling pathway in oxLDL-treated RAW264.7 macrophages. | Biofactors | 2024 | 38760074 | PubTator, text mining | PubMed |
| DNA methylation and type 2 diabetes: a systematic review. | Clin Epigenetics | 2024 | 38755631 | PubTator, text mining | PubMed |
| LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes. | J Clin Invest | 2024 | 38747290 | PubTator, text mining | PubMed |
| Genome- and epigenome-wide association studies identify susceptibility of CpG sites and regions for metabolic syndrome in a Korean population. | Clin Epigenetics | 2024 | 38685121 | PubTator, text mining | PubMed |
| Discovery of Small Molecule Glycolytic Stimulants for Enhanced ApoE Lipidation in Alzheimer's Disease Cell Model. | Pharmaceuticals (Basel) | 2024 | 38675451 | PubTator, text mining | PubMed |
| LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice. | Biomolecules | 2024 | 38672446 | PubTator, text mining | PubMed |
| Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease. | Atherosclerosis | 2024 | 38663317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9619/papers?page=10